|
| 1 |
Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis
Mee Kyoung Kim, Kyungdo Han, Hyuk-Sang Kwon, Soon Jib Yoo
|
|
| 2 |
Ticagrelor washout bridged with GPIIb/IIIa inhibitor infusion to facilitate surgical care following placement of pipeline flow diverters: a case report
Aaron Zweig, James S Stanley, Ronak Patel, John Agola, Michael R Halstead
|
|
| 3 |
Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
Seong Keun Kwon, Sung Joon Park, Eun-Jae Chung, Jin-Ho Sohn, Dong-Il Sun, Sung Min Jin, Byung-Joo Lee, Il-Seok Park, Jae-Gu Cho, Young Hak Park
|
|
| 4 |
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
Blood Res.2023;58(S1):S109-S113. Published online 2023 April 30
DOI: http://dx.doi.org/10.5045/br.2023.2023054
|
|
| 5 |
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
Diabetes Metab J.2023;47(4):500-513. Published online 2023 April 25
DOI: http://dx.doi.org/10.4093/dmj.2022.0110
|
|
| 6 |
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65. Published online 2023 April 7
DOI: http://dx.doi.org/10.5045/br.2023.2023035
|
|
| 7 |
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
Bokyung Kim, Jin-Hyung Jung, Kyungdo Han, Seungkyung Kang, Eunwoo Lee, Hyunsoo Chung, Sang Gyun Kim, Soo-Jeong Cho
|
|
| 8 |
Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A
Debadrita Ray, Narender Kumar, Chander Hans, Anita Kler, Richa Jain, Deepak Bansal, Amita Trehan, Arihant Jain, Pankaj Malhotra, Jasmina Ahluwalia
Blood Res.2023;58(1):61-70. Published online 2023 March 16
DOI: http://dx.doi.org/10.5045/br.2023.2022197
|
|
| 9 |
Novel therapeutics for myelofibrosis
Sung-Eun Lee
Blood Res.2023;58(S1):S13-S19. Published online 2023 March 9
DOI: http://dx.doi.org/10.5045/br.2023.2023012
|
|
| 10 |
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res.2023;58(S1):S29-S36. Published online 2023 March 9
DOI: http://dx.doi.org/10.5045/br.2023.2023017
|
|
| 11 |
EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.2023;55(3):841-850. Published online 2023 February 13
DOI: http://dx.doi.org/10.4143/crt.2022.1438
|
|
| 12 |
Prescription of Gastric Acid Secretion Inhibitors before and after the Withdrawal of Ranitidine
Jieun Yun
|
|
| 13 |
FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group
Novie Amelia Chozie, Djajadiman Gatot, Bambang Sudarmanto, Susi Susanah, Rini Purnamasari, Pudjo Hagung Widjajanto, Susanto Nugroho, Olga Rasiyanti, Dian Puspitasari, Muhammad Riza, Maria Christina Shanty Larasati, Sri Suryo Adiyanti, Made Citra Saraswati, Fitri Primacakti
Blood Res.2022;57(4):272-277. Published online 2022 December 31
DOI: http://dx.doi.org/10.5045/br.2022.2022153
|
|
| 14 |
Inhibition of Class I Histone Deacetylase Enhances Self-Reprogramming of Spermatogonial Stem Cells into Pluripotent Stem Cells
Yukyeong Lee, Seung-Won Lee, Dahee Jeong, Hye Jeong Lee, Na Young Choi, Jin Seok Bang, Seokbeom Ham, Kinarm Ko
Int J Stem Cells.2022;16(1):27-35. Published online 2022 December 31
DOI: http://dx.doi.org/10.15283/ijsc22110
|
|
| 15 |
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer
Hyun Ae Jung, Sehhoon Park, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jong-Mu Sun
Cancer Res Treat.2022;55(2):479-487. Published online 2022 December 27
DOI: http://dx.doi.org/10.4143/crt.2022.1344
|
|
| 16 |
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
Endocrinol Metab.2022;37(6):839-850. Published online 2022 December 26
DOI: http://dx.doi.org/10.3803/EnM.2022.1627
|
|
| 17 |
Effect of Afatinib for Lung Cancer on Papillary Thyroid Carcinoma
Sang Hwon Cho, Jin Seok Lee, Hyeok Jun Yun, Yong Sang Lee, Hang-Seok Chang
|
|
| 18 |
EID3 Promotes Glioma Cell Proliferation and Survival by Inactivating AMPKα1
Yaoxian Xiang, Lei Zhu, Zijian He, Lei Xu, Yuhang Mao, Junjian Jiang, Jianguang Xu
|
|
| 19 |
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response
Jung Yong Hong, Hee Jin Cho, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Sang Kyum Kim, Yurimi Lee, Yoon-La Choi, Minsuk Kwon, Hyo Song Kim, Jeeyun Lee
Cancer Res Treat.2023;55(2):671-683. Published online 2022 September 27
DOI: http://dx.doi.org/10.4143/crt.2022.251
|
|
| 20 |
Comparison of Homologous Recombination Repair Gene Next-Generation Sequencing Analysis in Patients With Metastatic Castration-Resistant Prostate Cancer Between Local and Central Laboratories in Korea
Yoonjung Kim, Inho Park, Boyeon Kim, Yu Jeong Choi, Seoung Chul Oh, Kyung-A Lee
Ann Lab Med.2023;43(1):64-72. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.64
|
|
